A single-arm clinical trial to evaluate the efficacy of Vanadium Metallicum in the management of anaemia in young females

This is a single arm interventional clinical study to evaluate the efficacy of Vanadium Metallicum 6X in the management of anaemia in young females aged 13 to 16 years with haemoglobin between 8 and 11 gram percent. A total of 30 participants will be selected from the hospital OPD and IPD and will receive Vanadium Metallicum 6X four tablets orally three times every 30 days and will be followed for a period of six months. The primary outcome is improvement in haemoglobin levels and associated clinical symptoms such as pallor fatigue weakness headache disturbed sleep impaired concentration and breathlessness. Haemoglobin will be assessed at baseline and during follow up visits using a standardized automated analyser